FRANCISCO JAVIER
GRANDAS PÉREZ
Profesor titular de universidad
![Foto de FRANCISCO JAVIER](/img/nophoto.png)
![Foto de German Center for Neurodegenerative Diseases](/img/noimage_org.png)
German Center for Neurodegenerative Diseases
Bonn, AlemaniaPublicaciones en colaboración con investigadores/as de German Center for Neurodegenerative Diseases (1)
2021
-
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
The Lancet Neurology, Vol. 20, Núm. 3, pp. 182-192